Axon Enterprise has delivered a strong run over the past five years, yet the valuation signals today are pulling in different directions, with the Discounted Cash Flow (DCF) estimate pointing to a premium while market multiples suggest the shares may still offer value on some metrics.
The issue now is whether Axon Enterprise’s current share price leaves enough margin between market expectations and intrinsic value to make that mixed valuation picture acceptable for new capital.
Spot opportunities beyond Axon Enterprise by filtering for 48 high quality undervalued stocks that combine solid cash flows with balance sheet strength, while the market focus is pulled toward higher profile growth stories.The Discounted Cash Flow (DCF) framework values Axon Enterprise on the cash it is expected to generate for shareholders over time. Over the last twelve months, the business produced about $136.8 million of free cash flow, and the model assumes that figure grows meaningfully in the coming years rather than staying flat or falling.
On those projections, the DCF model lands on an estimated intrinsic value of about $442 per share. Compared with the current market price, that implies the stock screens roughly 14.5% overvalued. The recent 30.4% price target increase from Argus to $600 helps explain why enthusiasm around Axon Enterprise can run ahead of what the cash flow analysis supports today.
On this cash flow view, Axon Enterprise currently screens as overvalued relative to its estimated intrinsic value.
Our Discounted Cash Flow (DCF) analysis suggests Axon Enterprise may be overvalued by 14.5%. Discover 48 high quality undervalued stocks or create your own screener to find better value opportunities.
P/S tends to fit Axon Enterprise because investors often key off recurring software and device contracts that lean on revenue scale more than near term earnings. On this metric, the stock trades at about 12.8x trailing sales, which sits below the peer group near 17.0x but well above the broader aerospace and defense industry on roughly 4.2x.
The fair P/S ratio, which blends Axon Enterprise’s growth profile, margins, sector and risk into one benchmark, comes out nearer 14.7x. That is modestly higher than where the shares change hands today, so the current tag implies a discount to what this framework suggests could be reasonable for the business.
On the P/S yardstick, Axon Enterprise appears undervalued relative to the revenue multiple implied by its fundamentals and peer set.
See what the numbers say about this price — find out in our valuation breakdown.
Simply Wall St Narratives pick up where the Axon Enterprise valuation puzzle leaves off by spelling out which future paths for growth, profitability and earnings would need to play out for the stock to be worth materially more or materially less than today's price on the Community page. Instead of only seeing a single figure from a ratio or model, you see the future conditions that figure relies on so you can monitor whether those assumptions continue to line up with reality.
One of the top community narratives on Axon Enterprise: 17% undervalued
"What began as a hardware business is increasingly becoming an ecosystem built around digital evidence, cloud software, and connected policing tools..."
Read one of the top narratives on Axon Enterprise
Do you think there's more to the story for Axon Enterprise? Head over to our Community to see what others are saying!
Axon Enterprise screens as overvalued on a Discounted Cash Flow (DCF) basis, yet looks undervalued when judged on its revenue multiple against peers. That split reflects two different stress points. The intrinsic value view leans on how quickly free cash flow can build, while the market multiple leans on investors continuing to pay up for Axon Enterprise’s growth profile. The crux from here is whether future cash generation can catch up with the optimism already embedded in the share price before sentiment toward high growth public safety technology cools.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com